Impact of super-extended lymphadenectomy on relapse in advanced gastric cancer

European Journal of Surgical Oncology

Volumn 41, Issue 4, 2015, Pages 534-540

  De Manzoni, G ^a   Verlato, G ^a   Bencivenga, M ^a   Marrelli, D ^b   Leo, A Di ^c   Giacopuzzi, S ^a   Cipollari, C ^a   Roviello, F ^b  

^a UNIVERSITY OF VERONA   (Italy)

^b UNIVERSITY OF SIENA   (Italy)

^c Institute of Anatomic Pathology S Maria   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; ADVANCED CANCER; ADVANCED GASTRIC CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PATIENT; CANCER RECURRENCE; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HISTOPATHOLOGY; HUMAN; INTESTINE; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MANTEL HAENSZEL TEST; MULTIMODALITY CANCER THERAPY; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; STOMACH CANCER; ADENOCARCINOMA; AORTA; CANCER STAGING; MIDDLE AGED; PATHOLOGY; PROCEDURES; RETROSPECTIVE STUDY; STOMACH NEOPLASMS; TUMOR RECURRENCE;

ADENOCARCINOMA; AGED; AORTA; FEMALE; GASTRECTOMY; HUMANS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS;

EID: 84929938978     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2015.01.023     Document Type: Article

References (34)

1. Ferlay J, Soerjomataram I, Ervik M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon, France: International Agency for Research on Cancer; 2013. Available from: http://globocan.iarc.fr. [accessed on 3.1.14].
2. Marrelli D, Pedrazzani C, Morgagni D, et al. On behalf of the Italian Research Group for Gastric Cancer (IRGGC). Changing clinical and pathological features of gastric cancer over time. Br J Surg 2011;98: 1273-83. http://dx.doi.org/10.1002/bjs.7528 PMID: 21560122.
3. Deng J, Liang H, Wang D, Sun D, Pan Y, Liu Y. Investigation of the recurrence patterns of gastric cancer following a curative resection. Surg Today 2011;41:210-5. http://dx.doi.org/10.1007/s00595-009-4251-y PMID: 21264756.
4. Spolverato G, Ejaz A, Kim Y, et al. Rates and patterns of recurrence after curative intent resection for gastric cancer: a United States multi-institutional analysis. J Am Coll Surg 2014;219(4):664-75. http://dx.doi.org/10.1016/j.jamcollsurg.2014.03.062 PMID: 25154671.
5. Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol 2010;11: 439-49. http://dx.doi.org/10.1016/S1470-2045(10)70070-X PMID: 20409751.
6. Sasako M, Sano T, Yamamoto S, et al. D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer. N Engl J Med 2008; 359:453-62. http://dx.doi.org/10.1056/NEJ- Moa0707035 PMID: 18669424.
7. Sano T, Sasako M, Yamamoto S, et al. Gastric cancer surgery: morbidity and mortality results from a prospective randomized controlled trial comparing D2 and extended para-aortic lymphadenectomy - Japan Clinical Oncology Group Study 9501. J Clin Oncol 2004;22:2767-73. http://dx.doi.org/10.1200/JCO.2004.10.184 PMID: 15199090.
8. Japanese Gastric Cancer Association. Japanese gastric cancer treatment guidelines 2010 (ver. 3). Gastric Cancer 2011;14:113-23. http://dx.doi.org/10.1007/s10120-011-0042-4 PMID: 1573742.
9. Roviello F, Pedrazzani C, Marrelli D, et al. Super-extended (D3) lymphadenectomy in advanced gastric cancer. Eur J Surg Oncol 2010; 36(5):439-46. http://dx.doi.org/10.1016/j.ejso.2010.03.008 PMID: 20392590.
10. de Manzoni G, Di Leo A, Roviello F, et al. Tumor site and perigastric nodal status are the most important predictors of para-aortic nodal involvement in advanced gastric Cancer. Ann Surg Oncol 2011;18: 2273-80. http://dx.doi.org/10.1245/s10434-010-1547-5 PMID: 21286941.
11. Marrelli D, Pedrazzani C, Neri A, et al. Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: analysis of potential risk factors. Ann Surg Oncol 2007;14:25-33. http://dx.doi.org/10.1245/s10434-006-9063-3 PMID: 17024558.
12. Günther K, Horbach T, Merkel S, et al. D3 lymph node dissection in gastric cancer: evaluation of postoperative mortality and complications. Surg Today 2000;30:700-5. http://dx.doi.org/10.1007/s005950070080 PMID: 10955732.
13. Bostanci EB, Kayaalp C, Ozogul Y, Aydin C, Atalay F, Akoglu M. Comparison of complications after D2 and D3 dissection for gastric cancer. Eur J Surg Oncol 2004;30:20-5. http://dx.doi.org/10.1016/j.ejso.2003.10.008 PMID: 14736518.
14. Verlato G, Roviello F, Marchet A, et al. Indexes of surgical quality in gastric cancer surgery: experience of an Italian network. Ann Surg Oncol 2009;16:594-602. http://dx.doi.org/10.1245/s10434-008-0271-x PMID: 19118437.
15. Marrelli D, Roviello F, de Manzoni G, et al. Different patterns of recurrence in gastric cancer depending on Lauren's histological type: longitudinal study. World J Surg 2002;26(9):1160-5. http://dx.doi.org/10.1007/s00268-002-6344-2 PMID: 12209247.
16. Japanese Gastric Cancer Association. Japanese classification of gastric carcinomad - 2nd English- editiond. Gastric Cancer 1998;1:10-24. PMID: 11957040.
17. Sobin LH, Gospodarowicz MK, Wittekind CH, editors. International Union Against Cancer (UICC) TNM classification of malignant tumors. 7th ed. Oxford: Wiley-Blackwell; 2009.
18. Laurén PA, Nevalainen TJ. Epidemiology of intestinal and diffuse types of gastric carcinoma. A time-trend study in Finland with comparison between studies from high- and low-risk areas. Cancer 1993;71:2926-33. PMID: 8490820.
19. Marrelli D, De Stefano A, de Manzoni G, et al. Prediction of recurrence after radical surgery for gastric cancer: a scoring system obtained from a prospective multicenter study. Ann Surg 2005;241: 247-55. http://dx.doi.org/10.1097/01.sla.0000152019.14741.97 PMID: 15650634.
20. Roviello F, Marrelli D, de Manzoni G, et al. Prospective study of peritoneal recurrence after curative surgery for gastric cancer. Br J Surg 2003;90:1113-9. http://dx.doi.org/10.1002/bjs.4164 PMID: 12945079.
21. D'Angelica M, Gonen M, Brennan MF, et al. Patterns of initial recurrence in completely resected gastric adenocarcinoma. Ann Surg 2004; 240:808-16. http://dx.doi.org/10.1097/01.sla.0000143245.28656.15 PMID: 15492562.
22. Yoo CH, Noh SH, Shin DW, et al. Recurrence following curative resection for gastric carcinoma. Br J Surg 2000;87:236-42. http://dx.doi.org/10.1046/j.1365-2168.2000.01360.x PMID: 10671934.
23. Maehara Y, Hasuda S, Koga T, Tokunaga E, Kakeji Y, Sugimachi K. Postoperative outcome and sites of recurrence in patients following curative resection of gastric cancer. Br J Surg 2000;87(3):353-7. http://dx.doi.org/10.1046/j.1365-2168.2000.01358.x PMID: 10718807.
24. Meyer HJ, Hölscher AH, Lordick F, et al. Current S3 guidelines on surgical treatment of gastric carcinoma. Chirurg 2012;83:31-7. http://dx.doi.org/10.1007/s00104-011-2149-x PMID: 22127381.
25. Allum WH, Blazeby JM, Griffin SM, Cunningham D, Jankowski JA, Wong R. Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland, the British Society of Gastroenterology and the British Association of Surgical Oncology. Guidelines for the management of oesophageal and gastric cancer. Gut 2011;60:1449-72. http://dx.doi.org/10.1136/gut.2010.228254 PMID: 2170545654.
26. Okines A, Verheij M, Allum W, Cunningham D, Cervantes A. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2010;21(Suppl. 5):v50-4. http://dx.doi.org/10.1093/annonc/mdq164 PMID: 20555102.
27. Waddell T, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO-ESSO-ESTRO Clinical 55 Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013; 24(Suppl. 6):vi57-63. http://dx.doi.org/10.1093/annonc/mdt344 PMID: 24078663.
28. De Manzoni G, Baiocchi GL, Framarini M, et al. The SIC-GIRCG 2013 Consensus Conference on gastric cancer. Updates Surg 2014;66(1):1-6. http://dx.doi.org/10.1007/s13304-014-0248-1 PMID: 24523031.
29. Verlato G, Giacopuzzi S, Bencivenga M, Morgagni P, De Manzoni G. Problems faced by evidence-based medicine in evaluating lymphadenectomy for gastric cancer. World J Gastroenterol 2014;20(36):12883-91. http://dx.doi.org/10.3748/wjg.v20.i36.12883. Review. PMID: 25278685.
30. Kunisaki C, Akiyama H, Nomura M, et al. Comparison of surgical results of D2 versus D3 gastrectomy (para-aortic lymph node dissection) for advanced gastric carcinoma: a multi-institutional study. AnnSurgOncol 2006;13(5):659-67. http://dx.doi.org/10.1245/ASO.2006.07.015 PMID: 16538414.
31. Esaki Y, Hirayama R, Hirokawa K. Comparison of patterns of metastasis in gastric cancer by histologic type and age. Cancer 1990;65(9): 2086-90. PMID: 2372774.
32. Tsuburaya A, Mizusawa J, Tanaka Y, Fukushima N, Nashimoto A, Sasako M. Stomach Cancer Study Group of the Japan Clinical Oncology Group. Neoadjuvant chemotherapy with S-1 and cisplatin followed by D2 gastrectomy with para-aortic lymph node dissection for gastric cancer with extensive lymph node metastasis. Br J Surg 2014;101(6): 653-60. http://dx.doi.org/10.1002/bjs.9484 PMID: 24668391.
33. de Martel C, Forman D, Plummer M. Gastric cancer: epidemiology and risk factors. Gastroenterol Clin North Am 2013;42(2):219-40. http://dx.doi.org/10.1016/j.gtc.2013.01.003 PMID: 23639638.
34. Henson DE, Dittus C, Younes M, et al. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973e2000: increase in the signet ring cell type. Arch Pathol Lab Med 2004;128:765-70. PMID: 15214826.